SEC Form 4 · accession 0001645627-17-000124
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 28, 2017
Accepted (ET)
Oct 2, 2017 · 1:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 28, 2017 | P | 3,000 | $0.044 | A | 23,611,189 | D | |
| Common Stock | Sep 28, 2017 | P | 3,000 | $0.043 | A | 23,614,189 | D | |
| Common Stock | Sep 29, 2017 | P | 5,000 | $0.0449 | A | 23,619,189 | D | |
| Common Stock | Sep 29, 2017 | P | 5,000 | $0.0515 | A | 23,624,189 | D | |
| Common Stock | Sep 29, 2017 | P | 5,000 | $0.0544 | A | 23,629,189 | D | |
| Common Stock | Sep 29, 2017 | P | 3,000 | $0.0545 | A | 23,632,189 | D | |
| Common Stock | Sep 29, 2017 | P | 2,000 | $0.0527 | A | 23,634,189 | D | |
| Common Stock | Sep 29, 2017 | P | 2,000 | $0.0527 | A | 23,636,189 | D | |
| Common Stock | Sep 29, 2017 | P | 5,000 | $0.0528 | A | 23,641,189 | D | |
| Common Stock | Sep 29, 2017 | P | 2,000 | $0.0547 | A | 23,643,189 | D | |
| Common Stock | Sep 29, 2017 | P | 3,000 | $0.0575 | A | 23,646,189 | D | |
| Common Stock | Sep 29, 2017 | P | 2,000 | $0.0575 | A | 23,648,189 | D | |
| Common Stock | Sep 29, 2017 | P | 2,000 | $0.0575 | A | 23,650,189 | D |
Table II — derivative securities
No Table II lines on this filing.